Redirect Notice

Looks like you clickedhttp://trilliumtherapeutics.com/investors/news/Press-Release-Details/2017/Trillium-Therapeutics-to-Present-New-Data-from-TTI-621-Phase-1-Trial/default.aspx

If you do not want to visit that page, you can close this browser tab.